Gilman Hill Asset Management’s Zimmer Biomet ZBH Stock Holding History

Gilman Hill Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.81M	Buy	55,886 +16,872	+43%	+$1.48M	0.66%	69
2026 Q1	$3.53M	Buy	39,014 +5,429	+16%	+$498K	0.53%	77
2025 Q4	$3.02M	Buy	33,585 +2,097	+7%	+$199K	0.48%	78
2025 Q3	$3.1M	Buy	31,488 +1,110	+4%	+$110K	0.49%	79
2025 Q2	$2.77M	Buy	30,378 +1,258	+4%	+$122K	0.45%	77
2025 Q1	$3.3M	Buy	29,120 +1,081	+4%	+$116K	0.57%	69
2024 Q4	$2.96M	Sell	28,039 -600	-2%	-$64.4K	0.52%	76
2024 Q3	$3.09M	Buy	28,639 +2,281	+9%	+$249K	0.52%	69
2024 Q2	$2.86M	Buy	26,358 +13,668	+108%	+$1.61M	0.52%	73
2024 Q1	$1.67M	Sell	12,690 -67	-0.5%	-$8.37K	0.3%	90
2023 Q4	$1.55M	Sell	12,757 -129	-1%	-$14.4K	0.29%	95
2023 Q3	$1.45M	Buy	12,886 +175	+1%	+$22.2K	0.28%	93
2023 Q2	$1.85M	Buy	12,711 +385	+3%	+$52.3K	0.34%	93
2023 Q1	$1.59M	Buy	12,326 +1,062	+9%	+$133K	0.32%	88
2022 Q4	$1.44M	Buy	11,264 +1,462	+15%	+$170K	0.29%	91
2022 Q3	$1.02M	Buy	9,802 +488	+5%	+$53.6K	0.24%	103
2022 Q2	$979K	Buy	9,314 +318	+4%	+$37.7K	0.21%	101
2022 Q1	$1.15M	Sell	8,996 -186	-2%	-$22.4K	0.26%	95
2021 Q4	$1.13M	Buy	9,182 +252	+3%	+$33K	0.25%	96
2021 Q3	$1.27M	Sell	8,930 -77	-0.9%	-$11.3K	0.32%	85
2021 Q2	$1.41M	Buy	9,007 +401	+5%	+$65K	0.36%	79
2021 Q1	$1.34M	Buy	8,606 +531	+7%	+$82.3K	0.37%	75
2020 Q4	$1.21M	Buy	8,075 +376	+5%	+$53.1K	0.39%	71
2020 Q3	$1.02M	Sell	7,699 -181	-2%	-$23.6K	0.39%	71
2020 Q2	$913K	Buy	7,880 +232	+3%	+$26.7K	0.36%	74
2020 Q1	$751K	Buy	7,648 +103	+1%	+$13.5K	0.36%	80
2019 Q4	$1.1M	Buy	7,545 +41	+0.5%	+$5.66K	0.36%	76
2019 Q3	$1M	Sell	7,504 -72	-1%	-$9.3K	0.33%	77
2019 Q2	$866K	Buy	7,576 +984	+15%	+$115K	0.29%	84
2019 Q1	$817K	Buy	6,592 +340	+5%	+$38.6K	0.29%	84
2018 Q4	$630K	Buy	6,252 +226	+4%	+$25.4K	0.27%	91
2018 Q3	$769K	Sell	6,026 -87	-1%	-$10.3K	0.3%	82
2018 Q2	$661K	Buy	6,113 +21	+0.3%	+$2.29K	0.27%	85
2018 Q1	$645K	Buy	6,092 +262	+4%	+$30.4K	0.28%	90
2017 Q4	$683K	Sell	5,830 -144	-2%	-$16.3K	0.28%	87
2017 Q3	$679K	Buy	5,974 +530	+10%	+$61.2K	0.28%	86
2017 Q2	$679K	Buy	5,444 +335	+7%	+$39.7K	0.29%	82
2017 Q1	$606K	Buy	5,109 +124	+2%	+$14.1K	0.26%	85
2016 Q4	$499K	Buy	4,985 +1,164	+30%	+$125K	0.18%	105
2016 Q3	$482K	Buy	3,821 +838	+28%	+$104K	0.19%	101
2016 Q2	$349K	Sell	2,983 -112	-4%	-$12.7K	0.14%	120
2016 Q1	$320K	Buy	3,095 +98	+3%	+$9.48K	0.15%	124
2015 Q4	$299K	Buy	2,997 +613	+26%	+$60K	0.14%	128
2015 Q3	$217K	Buy	2,384 +185	+8%	+$18.5K	0.11%	141
2015 Q2	$233K	Buy	+2,199	New	+$243K	0.11%	147

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

Gilman Hill Asset Management's ZBH Position: Q2 2026 in Review

Gilman Hill Asset Management increased its Zimmer Biomet (ZBH) stake by 43% in Q2 2026, buying an estimated $1.48M and bringing the position to 55,886 shares worth $4.81M. The position accounts for 0.66% of the portfolio, ranked #69.

Gilman Hill Asset Management first reported a position in ZBH in Q2 2015 and has held it in 45 quarters since. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Gilman Hill Asset Management held 55,886 shares of Zimmer Biomet worth $4.81M as of Q2 2026.
Gilman Hill Asset Management bought 16,872 Zimmer Biomet shares in Q2 2026, an estimated $1.48M.
Zimmer Biomet made up 0.66% of Gilman Hill Asset Management's portfolio in Q2 2026, its #69 holding.
Gilman Hill Asset Management first reported a position in Zimmer Biomet in Q2 2015 and has held it in 45 quarters since.
132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Gilman Hill Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.